Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Fortis raises Generale bid

Friday 05 June 1998 23:02 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

FORTIS AG, part of the the Dutch-Belgian financial services group Fortis, is raising its bid for Generale de Banque, the Belgian bank, in an offer valued at 28,675 Belgian francs per Generale share.

The offer comprises Fortis AG's earlier seven-for-three share exchange, plus a BFr2,715 cash payment, and a "cash guarantee" of BFr1,350, to protect shareholders against a fall in Fortis AG's share price. A Fortis spokesman said the cash guarantee was "a kind of warrant".

The offer represents a premium of 7.2 per cent over the current value of the rival offer by the Dutch bank ABN Amro, the spokesman said. The new offer is almost 16 per cent above Fortis's original offer, made on 18 May.

The spokesman declined to comment on the "poison pill" share issue being considered yesterday evening by the Generale board, which, if approved, would involve Generale issuing a further 10 per cent of capital to Fortis.

ABN Amro said yesterday it was surprised that Generale's board was meeting to discuss the use of a poison pill.

"We were not informed about this meeting," said a spokesman. "If they are really discussing this, we can only be very surprised."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in